Navigation Links
DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate)
Date:11/17/2011

ull prescribing information and visit the DEXILANT Website at www.DEXILANT.com.  

Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc.

Based in Deerfield, Ill., Takeda Pharmaceuticals North America, Inc. and Takeda Global Research & Development Center, Inc. are subsidiaries of Takeda Pharmaceutical Company Limited, the largest pharmaceutical company in Japan. The respective companies currently market oral diabetes, insomnia, rheumatology and gastroenterology treatments and seek to bring innovative products to patients through a pipeline that includes compounds in development for diabetes, cardiovascular disease, gastroenterology, neurology and other conditions. To learn more about these Takeda companies, visit www.tpna.com.  

This press release contains forward-looking statements about Takeda. Forward-looking statements include statements regarding Takeda's plans, outlook, strategies, results for the future, and other statements that are not descriptions of historical facts. Forward-looking statements may be identified by the use of forward-looking words such as "may," "believe," "will," "expect," "project," "estimate," "should," "anticipate," "plan," "assume," "continue," "seek," "pro forma," "potential," "target," "forecast," "guidance," "outlook" or "intend" or other similar words or expressions of the negative thereof. Forward-looking statements are based on estimates and assumptions made by management that are believed to be reasonable, though they are inherently uncertain and difficult to predict. Investors are cautioned not to unduly rely on such forward-looking statements.

Forward-looking statements involve risks and uncertainties that could cause actual results or experience to differ materially from that expressed or implied by the forward-looking statements. Some of these risks and
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
2. Data Presented at DDW About Rebound Symptoms in Healed Erosive Esophagitis Patients After Completion of Treatment with DEXILANT(TM) (dexlansoprazole)
3. Proton Pump Inhibitor DEXILANT(TM) (dexlansoprazole) Now Available in U.S. Pharmacies
4. KAPIDEX(TM) (dexlansoprazole) Renamed DEXILANT(TM) in U.S. to Avoid Name Confusion
5. New Study Results Analyzed the Use of KAPIDEX(TM) (dexlansoprazole) for Nighttime Heartburn in Adults with Non-Erosive GERD
6. White Smile Global Inc. Corporate Update on the White Smile Premier™ "At-Home" LED Teeth Whitening System and the White Smile Tooth Gloss™, Including Clinical Study, Product Manufacturing, and Distribution
7. 72 Prominent Personalized Medicine Products Available; A Five-Fold Increase in Five Years
8. Novation Awards ICU Medical, Inc. a New Contract to Supply Members With a Complete Line of Clinically-Preferred Critical Care Products
9. Landauer, Inc. Announces Acquisition of IZI Medical Products, LLC
10. Regado Biosciences, Inc. Presents Three Abstracts Pertaining to its Pipeline of Reversible Antithrombotic Agents, Including the Substudy Analyses of its Phase 2b RADAR Trial for REG1, its Lead Product Candidate, at the American Heart Association (AH
11. Apelon Provides Products and Services to Support Canadian Healthcare Data Standardization
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 24, 2015 Research ... of the "Future Horizons and Growth Strategies ... Shares and Country Forecasts" report to their ... in the European Blood Banking Market 2015 is ... help current suppliers and potential market entrants identify ...
(Date:7/1/2015)... LAWRENCEVILLE, N.J. , July 1, 2015  Celsion ... company, today announced that Michael H. Tardugno , ... the Cantor Fitzgerald,s Inaugural Healthcare Conference on Wednesday, July ... being held at Le Parker Meridien Hotel located at ... 10019. A copy of the ...
(Date:7/1/2015)... (Continental) announced it is expanding its Baltimore -based clinical studies network ... demand for unique patient populations.  Photo - ... ... ... "Continental hosts clinical studies for ...
Breaking Medicine Technology:European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 2European Blood Banking 2015: Future Horizons and Growth Strategies - Supplier Shares and Country Forecasts 3Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 3Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 4
(Date:7/1/2015)... ... July 01, 2015 , ... ... care, specialty, combo, and compounding pharmacy operations, announces the most recent positioning of ... Cardinal Health RBC event at the Venetian Las Vegas, Nevada. During ...
(Date:7/1/2015)... ... July 01, 2015 , ... The Collaborative for Children and Families ... Trust. The grant will allow CCF to improve quality of care and save costs ... formed to respond to many changes in New York’s Medicaid system. Experts agree that ...
(Date:7/1/2015)... ... 2015 , ... Did you know that infertility in men is more common ... Advanced Fertility Center of Texas (AFCT) would like to talk about some natural ways ... considered to be a “woman’s issue,” male fertility factors can play a role in ...
(Date:7/1/2015)... Florida (PRWEB) , ... July 01, 2015 , ... ... for society,” said lead author Lisa Stolzenberg, a Professor in FIU’s School of ... juveniles aged 12 to 17 years who participated in the National Survey on ...
(Date:7/1/2015)... ... ... Franklin University, one of the leading educators of working adults in central Ohio, ... the College of Health & Public Administration . , In his ... of Franklin University via curriculum planning, course scheduling, faculty staffing and development, and the ...
Breaking Medicine News(10 mins):Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Franklin University Appoints Dean of College of Health & Public Administration 2
... 9 - then in Chicago, LA and D.C., Effort ... vets,since World War I, NEW HAVEN, Conn., Nov. 8 ... of wheelchairs to,veterans in need at four VA Hospital locations on ... K of C service to the men and,women of the U.S. ...
... Ill.) Representing the interests of pain patients in light ... former President of the American Academy of Pain Medicine (AAPM) ... Act of 2007. , The crisis of ... those who suffer. It is now a social issue ...
... Introducing SharpGuard(TM) Microsurgical Guarded Knives For Use In ... ... /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ANP), ... it plans to exhibit its,SharpGuard(TM) product line as well as ...
... Companies to Focus Resources on Partnership to Develop Rapid Molecular ... Tests for Healthcare-Associated Infections -, SAN ... that 3M has informed the Company it no longer intends ... the,food testing industry. The companies expect to formally terminate the,collaboration ...
... CORDOVA, Calif., Nov. 8 ThermoGenesis,Corp. (Nasdaq: KOOL ... process, store, and administer therapeutic doses of adult,stem cells ... for,the first quarter of fiscal 2008. Revenues for ... with revenues of $4.3 million for the first quarter ...
... System to Aid ... Decision-Making, MILFORD, ... Waters(R) Synapt(TM) HDMS,System to hasten its drug discovery efforts in the ... herpes,hepatitis C, HIV, osteoporosis, osteoarthritis, and high blood pressure.,Installed in June, ...
Cached Medicine News:Health News:Knights to Distribute $1 Million Worth of Wheelchairs for Veterans 2Health News:National physician organization supports Capps-Rogers Bill at today's congressional briefing 2Health News:Angiotech To Participate In The American Academy Of Ophthalmology (AAO) 2007 Annual Meeting 2Health News:3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration 2Health News:3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration 3Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 2Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 3Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 4Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 5Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 6Health News:ThermoGenesis Corp. Reports First Quarter 2008 Results 7Health News:Medivir Reshapes Drug Discovery 2Health News:Medivir Reshapes Drug Discovery 3
For the quantitative determination of Inorganic Phosphorus in serum. Linearity: 12.0 mg/dl....
For the quantitative kinetic determination of amylase activity, using manual or automated procedures, in human serum and urine....
Intended for the quantitative determination of alphaamylase activity in serum. Single vial, dry powder reagent. Reaction: Kinetic. Wavelength: 405 nm. Linearity: 2000 U/L at 37C....
For the quantitative determination of Gamma-GT in serum. Kinetic Reaction measured at 405 nm. Linearity: 600 IU/L at 37C....
Medicine Products: